Skip Navigation

AIDSInfo logo

 
Home > Drugs > BMS-378806

BMS-378806
Drug Class: Microbicides
BMS-378806, also known as BMS-806, is a type of medicine called an entry inhibitor. Entry inhibitors work by blocking HIV from entering human cells.

HIV/AIDS-Related Uses
BMS-378806 is an investigational medicine that is not yet approved by the FDA for use outside of clinical trials. It is being studied for the treatment and prevention of HIV infection. This medicine does not cure HIV infection or AIDS and is being studied to reduce the risk of passing the virus to other people.

Dosage Form/Administration
BMS-378806 has been studied in oral form to be taken by mouth and also comes in a vaginal gel.

Contraindications
Individuals should tell a doctor about any medical problems before taking this medicine.

Possible Side Effects
Along with its desired effects, BMS-378806 may cause some unwanted effects. More studies are needed to learn about BMS-378806's possible side effects.

Drug and Food Interactions
A doctor should be notified of any other medications being taken, including prescription, nonprescription (over-the-counter), or herbal medications.

Clinical Trials
Click here to search ClinicalTrials.gov for trials that use BMS-378806.

Manufacturer Information
BMS-378806
  Bristol - Myers Squibb Co
  PO Box 4500
  Princeton,  NJ  08543-4500
  (800) 321-1335
    
Updated June 6, 2008